Navigation Links
InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies

LOS ANGELES, Feb. 28, 2011 /PRNewswire/ -- InstaCare Corp. (OTC Bulletin Board: ISCR), a leading fulfillment provider of direct to patient diabetes programs, a leading provider of prescription drugs, home testing products for the chronically ill, and a leading developer of revolutionary cell phone centric e-health products and technologies, announced today that on Thursday, February 24, 2011, the Company filed a utility process Patent Application with the United States Patent and Trademark Office (USPTO) to secure its proprietary and unique MD@Hand and MD@Work technologies. The patent is titled "HEALTHCARE INFORMATION MANAGEMENT AND COMMUNICATIONS SYSTEM AND METHOD." The Patent application  makes 104 separate claims. The company has received appropriate serial numbers from the USPTO recognizing the filing and the filing date.

With the filing of the full utility patent, the company plans to immediately engage and close several of its previously discussed strategic partnership arrangements with one or more major healthcare IT companies. These arrangements, when closed, are expected to have a material positive impact on the Company's revenue streams.

The Company also plans to file additional continuation in part patent applications covering (i) the Company's MD@Practice-Probe technologies; (ii) the Company's base communication technology for world-wide communication between cell phones and health data repositories and (iii) the Company's Medical Game Theory Methods and Processes specifically directed toward patient diagnosis and treatment protocols.

Robert Jagunich, Chairman of InstaCare Corp. commented, "After careful consultation with our intellectual property counsel, and after a recent favorable ruling from the U.S. Supreme court (BILSKI ET AL. v. KAPPOS, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR, PATENT AND TRADEMARK OFFICE) we have now elected to file our full utility Patent covering 104 separate claims for our MD@Hand and MD@Work technologies. Both of these products make use of the company's proprietary securitized permanent EMR applications designed specifically for smart cell phones. The steps we have taken will protect the company and its shareholders from efforts initiated by our competition, patent trolls and copycats."

Keith Berman, CFO of InstaCare Corp. commented, "Our concept of offering medical legacy system applications that conform to the latest EMR/HER standards and that run on cell phones, support our seminal belief that our MD@Hand and MD@Work are game changing products. Now that the healthcare market indecision is in the past, and with our full utility patent application on file, and additional continuation in part applications forthcoming, we will shortly publish a study completed in 2010 and recently updated, to provide our shareholders and the investment community with a third party evaluation of the potential economic value of our technologies. This study is a major part of our previously stated initiative to achieve a listing on the NYSE-Amex."

For more information about InstaCare Corp., Pharma Tech Solutions, Inc., MD@Hand, MD@Work or the revolutionary Genstrip, please visit InstaCare at or Pharma Tech Solutions at or call the company at (805) 446-2973.

Forward-Looking Statements:Forward-looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements.  We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934.  Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of February 28, 2011.  We anticipate that subsequent events and developments will cause our views to change.Contact: Keith Berman, Secretary and CFOinfo@instacare.net2660 Townsgate Road Suite 300 Westlake Village, CA 91361Ph : 805-446-1973 Fax: 805-446-1983

SOURCE InstaCare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA
2. InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011
3. Instacare Corp. Board of Directors Sets Growth Plans for 2010
4. Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products
5. instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
6. DSM Recognized With Profiles in Sustainability Award for Corporate Commitment to Sustainability and Innovations for Pharmaceutical Manufacturing
7. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
8. Vanda Pharmaceuticals Files Shelf Registration Statement
9. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
10. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
11. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
Post Your Comments:
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
(Date:11/26/2015)... WILMINGTON, North Carolina , 26 november ... Laboratories, Inc. (AAIPharma/CML) kondigt de geplande investering ... de uitbreiding van de laboratoria en het ... . De uitbreiding zal resulteren in ... waarmee wordt voldaan aan de groeiende behoeften ...
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... "When I was traveling, I was very ... "Many people catch diseases simply from sitting on such dirty toilet seats. I ... germs." , He developed the patent-pending QUDRATECS to eliminate the need to sit ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... located in central Michigan, have come together on Thanksgiving Day to share the ... available for viewing on the Serenity Point YouTube channel, patients displayed what they ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
Breaking Medicine News(10 mins):